Search for other papers by Genfeng Yu in
Google Scholar
PubMed
Search for other papers by Siyang Liu in
Google Scholar
PubMed
Search for other papers by Cheng Song in
Google Scholar
PubMed
Search for other papers by Qintao Ma in
Google Scholar
PubMed
Search for other papers by Xingying Chen in
Google Scholar
PubMed
Search for other papers by Yuqi Jiang in
Google Scholar
PubMed
Search for other papers by Hualin Duan in
Google Scholar
PubMed
Search for other papers by Yajun He in
Google Scholar
PubMed
Search for other papers by Dongmei Wang in
Google Scholar
PubMed
Search for other papers by Heng Wan in
Google Scholar
PubMed
Search for other papers by Jie Shen in
Google Scholar
PubMed
central sensitivity indices include the thyrotroph thyroxine resistance index (TT4RI) and TSH index (TSHI). The FT3/FT4 ratio reflects deiodinase activity and is a proxy for peripheral thyroid hormone sensitivity ( 21 ). Central resistance phenomena affect
Search for other papers by Stasa Ivkovic in
Google Scholar
PubMed
secretion (table 2 ) [ 1 ]. Total cholesterol serum concentration dropped significantly after the introduction of combined T4/T3 therapy. The same applied to LDL cholesterol (table 3 ). Table 2 Serum free thyroid hormone and TSH, FT3/FT4 ratio
Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Vicky Ryan in
Google Scholar
PubMed
Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom
Search for other papers by Lorna Ingoe in
Google Scholar
PubMed
Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Search for other papers by Scott Wilkes in
Google Scholar
PubMed
individuals over 80 years [ 34 ]. The other novel finding of our study is that the FT3/FT4 ratio increased slightly on average in the HT arm, despite the reduction in exogenous thyroid hormone dose. While this phenomenon has been noted previously with
Search for other papers by Leonidas Duntas in
Google Scholar
PubMed
be lower in the Se than in the placebo group, but Se did not affect LT4 dosage or FT3/FT4 ratio nor did the duration of disease modify any parameter. The statistically significant reduction ( P < 0.016) of the pathognomonic TPOAb titers in this study
Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Avais Jabbar in
Google Scholar
PubMed
Search for other papers by Arjola Bano in
Google Scholar
PubMed
Search for other papers by Lorna Ingoe in
Google Scholar
PubMed
Search for other papers by Peter Carey in
Google Scholar
PubMed
Search for other papers by Shahid Junejo in
Google Scholar
PubMed
Search for other papers by Honey Thomas in
Google Scholar
PubMed
Search for other papers by Caroline Addison in
Google Scholar
PubMed
Search for other papers by David Austin in
Google Scholar
PubMed
Search for other papers by John P Greenwood in
Google Scholar
PubMed
Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Search for other papers by Azfar G Zaman in
Google Scholar
PubMed
. Relationship between serum TSH and FT4 with CRP and all-cause mortality There was no significant independent association between serum TSH levels ( P = 0.11) nor FT4 concentrations ( P = 0.08) with CRP levels at baseline, whereas the FT3/FT4 ratio was
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Nicola Viola in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
. weeks to years), 131 I uptake (low vs. high), FT3/FT4 ratio (low vs. high), and vascular pattern at color Doppler (low vs. high) (Table 2 ). Table 2. Destructive thyroiditis and Graves’ hyperthyroidism during ICPi therapy: differential
Azienda USL, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Giorgia Spaggiari in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Valentina Gnarini in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Chiara Diazzi in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Marco Marino in
Google Scholar
PubMed
Search for other papers by Frank Tüttelmann in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Azienda USL, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
, there were no differences among the three groups (respectively p = 0.71; p = 0.34). No significant differences were found in serum levels of fT 3 (p = 0.59), fT 4 (p = 0.16), Ab anti-TG (p = 0.48), fT 3 /fT 4 ratio (p = 0.76) and fT 3 /TSH ratio (p
Search for other papers by Jacqueline Jonklaas in
Google Scholar
PubMed
Search for other papers by Antonio C. Bianco in
Google Scholar
PubMed
Search for other papers by Anne R. Cappola in
Google Scholar
PubMed
Search for other papers by Francesco S. Celi in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Heike Heuer in
Google Scholar
PubMed
Search for other papers by Elizabeth A. McAninch in
Google Scholar
PubMed
Search for other papers by Lars C. Moeller in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Anna M. Sawka in
Google Scholar
PubMed
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Search for other papers by Colin M. Dayan in
Google Scholar
PubMed
were more associated with clinical parameters such as atrial fibrillation, osteoporosis, cancer, and dementia than with TSH values even within the reference range [ 86 ]. The fT3:fT4 Ratio Is Altered on TH Replacement with LT4, Even with Similar TSH
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
Search for other papers by John E.M. Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Bochum, Germany
Search for other papers by Johannes W. Dietrich in
Google Scholar
PubMed
ELISA (Anti-TSH-Receptor; EUROIMMUN AG, Luebeck, Germany). Interrelational Measures As a simple estimate of the conversion of T 4 to T 3 , we used the FT 3 -FT 4 ratio of the molar serum concentrations of the hormones. We divided FT 4 by TSH
Search for other papers by Christian Trummer in
Google Scholar
PubMed
Search for other papers by Hannes Reiher in
Google Scholar
PubMed
Search for other papers by Verena Theiler-Schwetz in
Google Scholar
PubMed
Search for other papers by Marlene Pandis in
Google Scholar
PubMed
Search for other papers by Christian Gstettner in
Google Scholar
PubMed
Search for other papers by Peter Potzinger in
Google Scholar
PubMed
Search for other papers by Tilman Keck in
Google Scholar
PubMed
Search for other papers by Thomas R. Pieber in
Google Scholar
PubMed
Institute of Pathology, Medical University of Graz, Graz, Austria
Institute for Clinical Pathology, Johannes Kepler University, Linz, Austria
Search for other papers by Sigurd Lax in
Google Scholar
PubMed
Department of Neuropathology, Institute of Pathology, Medical University of Graz, Graz, Austria
Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria
Search for other papers by Johannes Haybaeck in
Google Scholar
PubMed
Search for other papers by Vinzenz Stepan in
Google Scholar
PubMed
Search for other papers by Stefan Pilz in
Google Scholar
PubMed
-GSU/TSH molar ratio is increased in most TSH-PitNETs [ 13 ]. Furthermore, increased serum concentrations of SHBG and bone turnover markers as well as an increased fT3/fT4 ratio were found to be indicative of autonomously TSH-secreting tumors. Additionally